Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 04:41 | 2026-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.18 | 6,287 | $158,320 | 121,150 | -4.9% |
| 2026-02-05 03:30 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $25.72 | 13,469 | $346,455 | 80,651 | -14.3% |
| 2026-01-08 01:46 | 2026-01-05 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $28.98 | 2,490 | $72,166 | 94,120 | -2.6% |
| 2026-01-03 02:12 | 2025-12-31 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $29.20 | 1,697 | $49,560 | 96,610 | -1.7% |
| 2025-12-18 01:53 | 2025-12-15 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $28.94 | 11,500 | $332,851 | 98,307 | -10.5% |
| 2025-11-11 01:41 | 2025-11-06 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $24.18 | 17,250 | $417,145 | 98,325 | -14.9% |
| 2025-11-06 02:57 | 2025-11-03 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $24.12 | 6,486 | $156,449 | 98,325 | -6.2% |
| 2025-08-22 04:32 | 2025-08-19 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.82 | 4,188 | $66,250 | 104,811 | -3.8% |
| 2025-08-13 00:04 | 2025-08-08 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.03 | 3,847 | $53,988 | 108,999 | -3.4% |
| 2025-08-06 01:28 | 2025-08-04 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.33 | 2,622 | $37,564 | 112,846 | -2.3% |
| 2025-07-14 23:02 | 2025-07-10 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $15.05 | 28,750 | $432,699 | 115,468 | -19.9% |
| 2025-05-10 02:45 | 2025-05-08 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.59 | 3,871 | $52,623 | 115,468 | -3.2% |
| 2025-05-06 00:20 | 2025-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.19 | 2,597 | $39,442 | 119,339 | -2.1% |
| 2025-03-17 23:51 | 2025-03-13 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $14.99 | 61,403 | $920,511 | 121,936 | -33.5% |
| 2025-03-05 03:44 | 2025-03-03 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $13.10 | 3,773 | $49,408 | 166,089 | -2.2% |
| 2025-02-05 04:00 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $12.70 | 12,116 | $153,873 | 114,862 | -9.5% |
| 2025-01-01 02:13 | 2024-12-31 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $14.00 | 1,691 | $23,674 | 126,978 | -1.3% |
| 2024-11-27 00:21 | 2024-11-22 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $10.14 | 16,023 | $162,515 | 128,669 | -11.1% |
| 2024-11-19 03:04 | 2024-11-14 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $10.29 | 69,226 | $712,619 | 128,669 | -35.0% |
| 2024-11-06 00:45 | 2024-11-04 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.68 | 15,441 | $134,093 | 179,418 | -7.9% |
| 2024-08-21 23:39 | 2024-08-19 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.29 | 1,728 | $14,318 | 194,859 | -0.9% |
| 2024-08-05 23:37 | 2024-08-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $9.02 | 13,206 | $119,106 | 196,587 | -6.3% |
| 2024-05-31 23:50 | 2024-05-29 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $8.73 | 72,952 | $636,703 | 209,793 | -25.8% |
| 2024-05-03 23:22 | 2024-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.74 | 9,555 | $83,490 | 259,745 | -3.5% |
| 2024-03-07 01:12 | 2024-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $11.12 | 4,782 | $53,182 | 269,300 | -1.7% |
| 2024-01-04 01:30 | 2024-01-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $3.54 | 1,325 | $4,692 | 57,032 | -2.3% |
| 2023-08-22 19:24 | 2023-08-21 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $7.04 | 1,605 | $11,302 | 58,357 | -2.7% |
| 2023-03-09 00:28 | 2023-03-06 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.26 | 851 | $12,989 | 59,962 | -1.4% |
| 2023-03-07 02:51 | 2023-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.83 | 1,751 | $27,713 | 39,813 | -4.2% |
| 2023-01-05 01:15 | 2023-01-03 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.01 | 1,475 | $22,136 | 41,564 | -3.4% |
| 2022-03-08 04:53 | 2022-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $16.85 | 1,011 | $17,032 | 43,039 | -2.3% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.